These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans. Peter A; Kovarova M; Staiger H; Machann J; Schick F; Königsrainer A; Königsrainer I; Schleicher E; Fritsche A; Häring HU; Stefan N Am J Physiol Endocrinol Metab; 2018 Mar; 314(3):E266-E273. PubMed ID: 29138227 [TBL] [Abstract][Full Text] [Related]
24. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease. Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475 [TBL] [Abstract][Full Text] [Related]
25. Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease. Lebensztejn DM; Białokoz-Kalinowska I; Kłusek-Oksiuta M; Tarasów E; Wojtkowska M; Kaczmarski M Adv Med Sci; 2014 Mar; 59(1):81-4. PubMed ID: 24797980 [TBL] [Abstract][Full Text] [Related]
26. The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease. Shipovskaya AA; Dudanova OP; Kurbatova IV Ter Arkh; 2018 Aug; 90(8):63-68. PubMed ID: 30701940 [TBL] [Abstract][Full Text] [Related]
27. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Farsi F; Mohammadshahi M; Alavinejad P; Rezazadeh A; Zarei M; Engali KA J Am Coll Nutr; 2016; 35(4):346-53. PubMed ID: 26156412 [TBL] [Abstract][Full Text] [Related]
28. Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease. Malin SK; Mulya A; Fealy CE; Haus JM; Pagadala MR; Scelsi AR; Huang H; Flask CA; McCullough AJ; Kirwan JP J Appl Physiol (1985); 2013 Oct; 115(7):988-94. PubMed ID: 23928114 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease. Gangarapu V; Ince AT; Baysal B; Kayar Y; Kılıç U; Gök Ö; Uysal Ö; Şenturk H Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):840-5. PubMed ID: 26043290 [TBL] [Abstract][Full Text] [Related]
31. Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease. Ebert T; Linder N; Schaudinn A; Busse H; Berger J; Lichtinghagen R; Keim V; Wiegand J; Karlas T Endocrine; 2017 Nov; 58(2):246-252. PubMed ID: 28914407 [TBL] [Abstract][Full Text] [Related]
32. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD. Hossain IA; Rahman Shah MM; Rahman MK; Ali L Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S25-9. PubMed ID: 26482965 [TBL] [Abstract][Full Text] [Related]
33. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis. Ito S; Yukawa T; Uetake S; Yamauchi M Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172 [TBL] [Abstract][Full Text] [Related]
34. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. Bugianesi E; Pagotto U; Manini R; Vanni E; Gastaldelli A; de Iasio R; Gentilcore E; Natale S; Cassader M; Rizzetto M; Pasquali R; Marchesini G J Clin Endocrinol Metab; 2005 Jun; 90(6):3498-504. PubMed ID: 15797948 [TBL] [Abstract][Full Text] [Related]
35. Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver disease. Tapan S; Dogru T; Kara M; Ercin CN; Kilciler G; Genc H; Sertoglu E; Acikel C; Kilic S; Karslioglu Y; Kurt I; Erbil MK Scand J Clin Lab Invest; 2010 Oct; 70(6):399-403. PubMed ID: 20604719 [TBL] [Abstract][Full Text] [Related]
36. Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease. Kara M; Dogru T; Genc H; Sertoglu E; Celebi G; Gurel H; Kayadibi H; Cicek AF; Ercin CN; Sonmez A Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1144-8. PubMed ID: 26062078 [TBL] [Abstract][Full Text] [Related]
37. Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease. Chang EJ; Yi DY; Yang HR J Korean Med Sci; 2015 Dec; 30(12):1821-7. PubMed ID: 26713058 [TBL] [Abstract][Full Text] [Related]
38. Serum fetuin-A and arginase-1 in human obesity model: Is there any interaction between inflammatory status and arginine metabolism? Tanrikulu-Küçük S; Koçak H; Öner-İyidoğan Y; Seyithanoğlu M; Topparmak E; Kayan-Tapan T Scand J Clin Lab Invest; 2015 Jul; 75(4):301-7. PubMed ID: 25723054 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver disease. Hendy OM; Elsabaawy MM; Aref MM; Khalaf FM; Oda AMA; El Shazly HM APMIS; 2017 Jul; 125(7):607-613. PubMed ID: 28430371 [TBL] [Abstract][Full Text] [Related]
40. Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis. Genc H; Dogru T; Tapan S; Kara M; Ercin CN; Aslan F; Kantarcioglu M; Karslioglu Y; Sertoglu E; Erbil MK; Bagci S Scand J Gastroenterol; 2011 Nov; 46(11):1355-61. PubMed ID: 21770819 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]